CCN1/Cyr61 (cysteine‐rich angiogenic inducer 61) and CCN2/CTGF (connective tissue growth factor) have been implicated in various stages of cancer progression, including tumor initiation, angiogenesis, invasion, and metastasis.28 This evidence concerns the gene CCN2 and cancer.